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Introduction
Endothelial dysfunction plays a key role in sepsis physio-
pathology, leading to multiorgan failure and death. Circu-
lating endothelial cells (CECs) and circulating endothelial
progenitor cells (CEPCs) may be elevated in septic syn-
drome as a result of endothelial damage. Previous studies
have shown conflicting results and their role in septic syn-
drome remains unclear [1,2].
Objectives
Compare the number of circulating endothelial cells
(CECs) and circulating endothelial progenitor cells
(CEPCs) in septic and non-infectious systemic inflamma-
tory response syndrome (SIRS) and controls; and evaluate
their association with outcome.
Methods
Blood samples from patients affected with septic syndrome
(sepsis, severe sepsis and septic shock) and SIRS were pro-
spectively collected within the first 24 hours and after 96
hours of symptoms onset. Patients with malignancies were
excluded. A healthy control group was included (n= 15).
CECs (defined as CD45-, CD146+ and CD31+) and
CEPCs (defined as CD45-, CD34+ and KDR+) count were
determined by flow cytometry and were calculated to
obtain their absolute number per 1 mL of whole blood.
Results
Fifty-seven patients were included in the study: sepsis
(n = 20), severe sepsis (n = 10), septic shock (n = 16)
and non-infectious SIRS (n = 11). Sixty-five percent
were male and median age was 68 years. Most of the
patients presented non-surgical pathologies (93%).
Patients of all groups presented higher number of CECs
and CEPCs than healthy volunteers in baseline (p <
0.001 and 0.034 respectively). A positive correlation was
found between CECs and CEPCs count in the first day in
all groups (p < 0.001). CECs and CEPCs count decreased
significantly in patients with severe sepsis/septic shock at
96 hours (p = 0.034). There were not significant differ-
ences between CECs and CEPCs count either between the
different groups or survivors and non-survivors. We did
not find any correlation between the number of CECs or
CEPCs and severity or organ dysfunction at any time
point.
Conclusions
Patients with SIRS of infectious and non-infectious origin
present an increase of CECs and CEPCs count. However,
different septic syndrome and non-infectious SIRS do not
present differences in these count. Finally, CECs and
CEPCs count seem not associated with survival or illness
severity in these patients.
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